The PROTECT Trial Physical Activity and Exercise During Early Treatment for Children With Acute Lymphoblastic Leukaemia to Protect Against Sarcopenia and Improve Frailty Outcomes: a Pilot Randomised Controlled Trial
This is a small trial testing out a new approach before doing a bigger study. Researchers are observing a group of children/adolescents (ages 5-17) with acute lymphoblastic leukemia (ALL) and testing a physical activity and exercise program on a group of them who after 5 weeks of treatment show signs of weakness or frailty. Kids who are NOT losing muscle aren't part of the exercise trial - they're just monitored over time to see how they do. The goal: To see if an exercise program helps kids who are getting weaker from acute lymphoblastic leukemia treatment build back/maintain their strength, compared to kids who don't do the extra intervention. The study will also look at if this way of measuring muscle weakness works well for kids with cancer.
• Aged 5-17 years at the time of consent
• New diagnosis of acute lymphoblastic leukaemia \<7 days
• Is planned to receive management for their cancer treatment at the trial site for the duration of the trial period
• Has a legally acceptable representative capable of understanding the informed consent document in English and providing consent on the participant's behalf
• Have a family electronic device that can be linked with the tool to be used (Fitbit)